| Fund ID | 805-6601792131 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 2% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 98% |
| Fund | Type | Gross assets |
|---|---|---|
| Blackstone Life Sciences V L.P. | Private Equity | $6.13B |
| Blackstone Life Sciences VI L.P. | Private Equity | $1.4B |
| Blackstone Life Sciences Yield Nt L.P. | Other Private | $806.7M |
Blackstone Life Sciences V (lux) Scsp reports $544.7 million in gross assets, among the top 13% of private funds by size.
The stated minimum investment is $10 million.
Blackstone Life Sciences V (lux) Scsp is managed by Blackstone Life Sciences Advisors L.L.C.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.